Skip to main content
Clinical Trials/DRKS00023791
DRKS00023791
Completed
Phase 4

Randomized controlled pilot study of the clinical efficacy of the Mika App - MIKA

Fosanis GmbH0 sites70 target enrollmentFebruary 24, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
C51-C58
Sponsor
Fosanis GmbH
Enrollment
70
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 24, 2022
End Date
October 20, 2020
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Fosanis GmbH

Eligibility Criteria

Inclusion Criteria

  • possession of a smartphone
  • \- diagnosed carcinoma (ovary, endometrium, cervix)
  • \- German speaking

Exclusion Criteria

  • \- no secured diagnosis of carcinoma
  • \- not able to give informed consent
  • \- diagnosis more than 5 years ago
  • \-lack of smartphone or tablet skills

Outcomes

Primary Outcomes

Not specified

Similar Trials